Company: ISRG
Filing Date: 2025-03-14
Form Type: DEF 14A
Source: 0001035267-25-000098
Chunk: 27

Company: INTUITIVE SURGICAL INC
Filing Date: 2025-03-14
Form: DEF 14A
Chunk 27
---
 |     416.3 |     |     |       -100 | % |

(*) Non-GAAP Financial Measures. Non-GAAP financial measures should be viewed in addition to, and not as an alternative for, financial results prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). See the section “Non-GAAP Financial Measures” in this Proxy Statement for more information about these non-GAAP financial measures and for a reconciliation of these non-GAAP financial measures to the most comparable GAAP financial measures.

28

#### Recent Operational Highlights
• Instruments and accessories revenue increased by 19% to $5.08 billion for the year ended December 31, 2024, compared to $4.28 billion for the year ended December 31, 2023. Systems revenue increased by 17% to $1.97 billion for the year ended December 31, 2024, compared to $1.68 billion for the year ended December 31, 2023. Service revenue increased by 12% to $1.31 billion for the year ended December 31, 2024, compared to $1.17 billion for the year ended December 31, 2023.

• U.S. da Vinci procedures increased approxim ately 15% for the year ended December 31, 2024, as compared to the prior year. The 2024 U.S. procedure increase was driven by strong growth in general surgery procedures, most notably cholecystectomy, hernia repair, and colorectal procedures . The number of U.S. da Vinci bariatric procedures performed declined modestly in 2024 compared to 2023.

• Outside of U.S. (“OUS”) da Vinci procedures grew approximatel y 23% for the year ended December 31, 2024, as compared to the prior year. 2024 OUS procedure growth was driven by growth in general surgery procedures, most notably colorectal and hernia repair procedures, urologic procedures, most notably prostatectomy and partial nephrectomy procedures, and gynecologic procedures. Geographically, the 2024 OUS da Vinci procedure growth was driven by procedure expansion in a numb er of markets with particular strength in Germany, the UK, India, and Italy. In South Korea, we believe the number of procedures performed in 2024 was significantly affected by doctor strikes.

• As of December 31, 2024, we had a da Vinci surgical system installed base of approximately